Celularity
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Celularity generated cash of -$38,685,000, which is more than the previous year. Cash used in financing activities reached the amount of $24,094,000 last year. Net change in cash is therefore -$18,639,000.

Cash Flow

Celularity Inc. (NASDAQ:CELUW): Cash Flow
2019 -1.09M -286.84M 288.83M
2020 -63.19M -12.81M 102.01M
2021 -110.09M -5.90M 98.56M
2022 -137.87M -5.23M 119.83M
2023 -38.68M -4.04M 24.09M

CELUW Cash Flow Statement (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
28.80M52.07M69.51M43.50M24.70K
Operating activities
Net income
-196.29M14.19M-100.11M-208.23M5.87M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
9.32M9.43M8.81M8.17M6.18M
Stock-based compensation expense
15.01M15.85M40.01M4.37M3.66M
Deferred income tax benefit 15.01M15.85M40.01M4.37M3.66M
Changes in operating assets and liabilities:
Accounts receivable, net
-6.82M-3.58M-1.90M1.65M134K
Inventories
-865K-16.89M-6.42M-643K-1.70M
Accounts payable
8.49M-2.94M3.00M314K18.88K
Cash generated by operating activities
-38.68M-137.87M-110.09M-63.19M-1.09M
Investing activities
Purchases Of Investments
0000-287.5M
Investments In Property Plant And Equipment
-1.04M-5.23M-6.20M-27.83M-31.57M
Acquisitions Net
00015.01M0
Cash generated by investing activities
-4.04M-5.23M-5.90M-12.81M-286.84M
Financing activities
Common Stock Issued
21.88M36.51M83.4M102.67M288.98M
Payments for dividends
00000
Repurchases of common stock
000-256K0
Repayments of term debt
17.36M85.69M-5M00
Cash used in financing activities
24.09M119.83M98.56M102.01M288.83M
Net Change In Cash
-18.63M-23.27M-17.43M26.00M892.3K
Cash at end of period
10.16M28.80M52.07M69.51M917.00K
Data sourceData sourceData sourceData sourceData source